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1. Introduction 
Glycogen breakdown and synthesis as well as 
lipolysis are subject to regulation by cyclic AMP- 
protein kinase-mediated phosphorylation of phospho- 
rylase b kinase, [ 1,2] , glycogen synthase a [2] and 
hormone-sensitive triglyceride lipase [3,4] . The im- 
plications of the cyclic AMP-protein kinase system 
in the hormonal control of these metabolic pathways 
might be of relevance in diabetes and adrenocortical 
failure, since in the absence of insulin, glycogen and 
lipid metabolism are severely impaired, and since 
adrenalectomy considerably reduces the response of 
the liver [S, 61 and adipose tissue to hormonal stimuli 
[6,7, lo]. The latter has been attributed to the loss of 
the so-called permissive effect of glucocorticoids. It 
has been shown by Schaeffer et al. [5] in liver and by 
Exton et al. [6] in adipose tissue that the metabolic 
lesion lies beyond adenylcyclase. 
Therefore, it seemed of interest to examine wheth- 
er protein kinase and cyclic AMP-binding undergo 
any changes in liver and adipose tissue of diabetic and 
adrenalectomized animals. 
2. Materials and methods 
2.1. Animals 
Male Osborne-Mendel rats weighing between 140 
and 160 g were used throughout. They were fed nor- 
mal chow. Diabetes was induced by intravenous ad- 
ministration of streptozotocln (Hoffmann-La Roche, 
Basel), 70 mg/kg. Adrenalectomy was carried out in 
North-Holland Publishing Company - Amsterdam 
ether-aneasthetised animals by paravertebral incisions. 
Diabetic animals were sacrificed 5 days after the 
streptozotocin injection (blood sugar 400-500 mg%) 
and adrenalectomized animals 5 days after the oper- 
ation. 
2.2. Tissue preparation 
After decapitation of the animals, tissues were ra- 
pidly excised and frozen in liquid nitrogen. Livers 
were perfused with cold 4 mM EDTA, pH 7.0 prior to 
freezing. The tissues were stored at -20” C until ho- 
mogenization which was performed at 4” C in 5 vol 
of 4 mM EDTA, pH 7.0. 
Homogenates were centrifuged at 30 000 g and 
4’ C for 30 min and the cle& supernatants were used 
for protein kinase and cyclic AMP-binding assays after 
appropriate dilution. 
2.3. Protein kinase assay 
Protein kinase assays were performed by the meth- 
od of Walsh et al. [ 1 l] with slight modifications. The 
assay medium contained in a volume of 0.25 ml: sodi- 
um glycerol phosphate buffer, pH 6.0, 12.5 nmoles; 
theophylline 0.75 pmoles; NaF 2.5 pmoles; EDTA 
0.2 pmoles; casein (Serva, Heidelberg) 1.5 mg; be-. 
tween 100 and 200 pg of tissue protein; cyclic AMP, 
as added, 2.5 pmoles; and [T-~~P] ATP (Amersham, 
Radiochemical Centre) 0.25 bmoles ($5-3 X lo6 
cpm). After 5 min of incubation at 30 C the reaction 
was stopped by addition of 0.5 ml of 0.625% serum 
albumin and 2.5 ml of 10% trichloroacetic.acid. 32P 
incorporation into casein was determined according 
to De Lange et al. [ 121. 
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Fig. 1: A) Time course of phosphorylation of casein by crude tissue extracts of adipose tissue (180 pg of tissue protein) and liver 
(168 pg of tissue protein) in the absence (open symbols) and presence (closed symbols) of 10 -‘M cyclic AMP. Assay as described 
in Materials and methods; B) 32 P mcorporation into casein by various amounts of protein from adipose tissue and liver i”, the ab- 
sence (open symbols) and presence (closed symbols) of 10e5M cyclic AMP. Incubations were carried out for 5 min at 30 C al 
described in the text. 
All values were corrected for endogenous 32P incor- 
poration in the absence of casein. 
2.4. Determination of cyclic AMP-binding activity 
This was carried out according to the procedure of 
Walton and Garren [ 131. The reaction mixture con- 
tained in a total volume of 0.2 ml: Tris-HCI buffer, 
pH 7.5, 10 pmoles; MgCl, 2 pmoles; theophylline 3.2 
pmoles; between 100 and 200 pg of tissue protein and 
13.3 pmoles of [3H] cyclic AMP (50 nCi; Amersham. 
Radiochemical Centre). Incubations lasted 30 min at 
25” C. A similar procedure has lately been used in our 
laboratory for measuring cyclic AMP levels in liver 
perfusates [ 141. 
3. Results and discussion 
Since many factors may influence the kinase reac- 
tion in crude tissue preparations, assay conditions 
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were used in which the reaction kinetics were linear. 
Fig. 1 A shows that 32P incorporation into casein in 
the absence and presence of 1 O-sM cyclic AMP is lin- 
ear over 7- 10 min with both tissue extracts. With 
ATP concentrations lower than 1 mM (0.2 and 0.05 
mM) the reaction rate significantly decreases after 
2-3 min (not shown). As demonstrated in fig. 1B the 
reaction is linear only at tissue concentrations below 
200 clg per 0.25 ml of assay medium. One may see 
from fig. 1A and 1B that the ratio of cyclic AMP- 
stimulated to unstimulated protein kinase activities 
remains constant during the incubations. All these cri- 
teria indicate that neither ATP- nor cyclic AMP-degra- 
dation affect the kinase reaction to a detectable ex- 
tent under the conditions applied. 
A similar linear relationship is observed for cyclic 
AMP-binding (fig. 2) if the amount of tissue protein 
in the assay does not exceed 200 pg. 
Figs. 3A and 3B show that in the diabetic liver bas- 
al (unstimulated) and cyclic AMP-stimulated (total) 
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Fig. 2. Cyclic AMP-binding by various amounts of protein 
from adipose tissue (m-9-e) and liver (e-e-e). Assay conditions 
are given in the text. 
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protein kinase activities are reduced by 35%, and 
cyclic AMP-binding by 3%, probably reflecting de- 
creased protein kinase de novo synthesis during insulin 
deficiency. Changes in cyclic AMP levels in viva which 
might cause a shift of the equilibrium between the 
holoenzyme RC and the catalytic sub-unit C [ 151 
would only influence unstimulated but not total 
kinase activity. Besides, the state of this equilibrium 
within the intact cell is not very likely to persist 
throughout the killing of the animals and the subse- 
quent homogenization of the tissue. However, in con- 
trast to the findings of Corbin et al. [16] reconstitu- 
tion of the regulatory and catalytic sub-units does not 
take place in our assay system since the ratio between 
cyclic AMP-stimulated and unstimulated kinase activ- 
ities does not increase but remains constant upon di- 
lution (fig. 1B). 
Adrenalectomy is without effect on protein kinase 
and cyclic AMP-binding activities in liver (figs. 3A 
and 3B) suggesting that in this organ insulin rather 
than glucocorticoids is necessary to maintain normal 
levels of these proteins. Furthermore, this finding ren- 
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Fii. 3. Specitk activities of cyclic AMP-stimulated (16’M cyclic AMP; whole columns) and unstimulated (hatched columns) 
protein kinase (3A) and specific cyclic AMP-binding activities (3B) in crude liver and adipose tissue preparations (30 000 g super- 
natants) from normal (N), diabetic (D) and adrenalectomized (ADX) rats. In parentheses, number of animals tested; the bars give 
the standard error of the mean. The assays are described in the text. 
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ders it unlikely that the failure of the liver of adrenal- 
ectomized animals to respond adequately to hor- 
mones which stimulate glucose mobilization is quanti- 
tatively related to impaired de novo synthesis of pro- 
tein kinase or cyclic AMP-binding protein. 
In adipose tissue the absence of glucocorticoids as 
well as insulin deficiency cause a 30% decrease of pro- 
tein kinase activity, whereas cyclic AMP-binding is 
the same as in normal adipose tissue (figs. 3A and 3B). 
These results are not only compatible with decreased 
de novo synthesis of protein kinase, but, in addition, 
with an increase of the protein kinase inhibitor. The 
latter has been shown by Walsh et al. to form an inac- 
tive complex with the enzyme but to cause increased 
cyclic AMP-binding at nucleotide concentrations be- 
low 10e7M [ 17, 181. At normal protein kinase levels 
an increase of the kinase inhibitor alone could also ac- 
count for lower enzyme activities, but cyclic AMP- 
binding would be increased above normal. Therefore, 
decreased de novo synthesis of kinase must, in addi- 
tion, be inferred to explain normal cyclic AMP-bmd- 
ing and decreased kinase activities. Since the ratio of 
cyclic AMP-binding to protein kinase activity is in- 
creased (as calculated from figs. 3A and 3B) the same 
cyclic AMP levels would be less effective in activating 
protein kinase than in normal adipose tissue. This 
could, at least in part, account for the insufficient re- 
sponse of adipose tissue to lipolytic hormones after 
adrenalectomy, and it would provide a means of at- 
tenuating the bombardment by lipolytic hormones of 
adipose tissue in the absence of insulin, which in nor- 
mal adipose tissue counteracts their effects. 
The decrease of both cyclic AMP-stimulated and 
unstimulated kinase activities is in contrast to the ele- 
vated levels of inactive (phosphorylated) glycogen 
synthase in livers of diabetic rats [ 19,201, and to the 
increased rate of lipolysis in diabetic fat pads pointing 
to a fairly active (phosphorylated) triglyceride lipase. 
Maybe elevated cyclic AMP levels (as observed in 
livers of alloxan-diabetic rats, [21], overcompensate 
for the decrease of kinase activity. A more attractive 
explanation would be that the imbalance of the phos- 
phorylation-dephosphorylation cycle in diabetes 
might result in decreased dephosphorylation of these 
enzymes. 
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